XML 44 R38.htm IDEA: XBRL DOCUMENT v3.26.1
Business Combinations and Contingent Consideration Liabilities - Additional Information (Details)
 3 Months Ended
Feb. 08, 2023
Mar. 31, 2026
USD ($)
Mar. 31, 2025
USD ($)
Business Combination [Line Items]      
Fair value   $ 38,000  
Chronix [Member]      
Business Combination [Line Items]      
Fair value   $ 5,900,000  
Merger Agreement [Member] | Chronix Equity [Member]      
Business Combination [Line Items]      
Earnout percentage on collections for sales 10.00%    
Gross proceeds percentage 5.00%    
Insight Genetics Inc [Member] | Discount rate [Member] | Level 3 [Member]      
Business Combination [Line Items]      
Business combination, contingent consideration, liability, measurement input   0.137  
Insight Genetics Inc [Member] | Maximum [Member] | Discount rate [Member] | Level 3 [Member]      
Business Combination [Line Items]      
Business combination, contingent consideration, liability, measurement input     0.134
Insight Genetics Inc [Member] | Maximum [Member] | Management probability estimate [Member] | Level 3 [Member]      
Business Combination [Line Items]      
Business combination, contingent consideration, liability, measurement input   0.50 0.50
Insight Genetics Inc [Member] | Maximum [Member] | Expected term [Member] | Level 3 [Member]      
Business Combination [Line Items]      
Business combination, contingent consideration, liability, milestone payment   1 year 10 months 24 days 7 years 6 months
Insight Genetics Inc [Member] | Minimum [Member] | Discount rate [Member] | Level 3 [Member]      
Business Combination [Line Items]      
Business combination, contingent consideration, liability, measurement input     0.132
Insight Genetics Inc [Member] | Minimum [Member] | Management probability estimate [Member] | Level 3 [Member]      
Business Combination [Line Items]      
Business combination, contingent consideration, liability, measurement input   0.25 0.25
Insight Genetics Inc [Member] | Minimum [Member] | Expected term [Member] | Level 3 [Member]      
Business Combination [Line Items]      
Business combination, contingent consideration, liability, milestone payment   1 year 8 months 12 days 1 year 8 months 12 days
Insight Genetics Inc [Member] | Valuation Technique, Discounted Cash Flow [Member]      
Business Combination [Line Items]      
Unobservable Measurement Input, Uncertainty, Description   The significant unobservable inputs used in IGI’s contingent consideration valuation on March 31, 2026, included: (i) a discount period, based on the expected Milestone payment dates, ranging from 1.7 years to 1.9 years, (ii) a discount rate of 13.7%, and (iii) a management probability estimate of 25% to 50%. The significant unobservable inputs used in IGI’s contingent consideration valuation on March 31, 2025, included: (i) a discount period, based on the expected Milestone payment dates, ranging from 1.7 years to 7.5 years, (ii) a discount rate of 13.2% to 13.4%, and (iii) a management probability estimate of 25% to 50%.  
Chronix Merger [Member]      
Business Combination [Line Items]      
Deferred tax assets related to contingent consideration   $ 0 $ 0
Chronix Merger [Member] | Level 3 [Member]      
Business Combination [Line Items]      
Payout percentage   10.00% 10.00%
Chronix Merger [Member] | Maximum [Member] | Discount rate [Member] | Level 3 [Member]      
Business Combination [Line Items]      
Business combination, contingent consideration, liability, measurement input   0.142 0.135
Chronix Merger [Member] | Maximum [Member] | Expected term [Member] | Level 3 [Member]      
Business Combination [Line Items]      
Business combination, contingent consideration, liability, related patent expiration range term   9 years 6 months 10 years 6 months
Chronix Merger [Member] | Minimum [Member] | Discount rate [Member] | Level 3 [Member]      
Business Combination [Line Items]      
Business combination, contingent consideration, liability, measurement input   0.137 0.132
Chronix Merger [Member] | Minimum [Member] | Expected term [Member] | Level 3 [Member]      
Business Combination [Line Items]      
Business combination, contingent consideration, liability, related patent expiration range term   8 years 7 months 6 days 9 years 7 months 6 days
Chronix Merger [Member] | Valuation Technique, Discounted Cash Flow [Member]      
Business Combination [Line Items]      
Unobservable Measurement Input, Uncertainty, Description   The significant unobservable inputs used in Chronix’s contingent consideration valuation on March 31, 2026, included: (i) a discount period, based on the related patent expiration dates, ranging from 8.6 years to 9.5 years, (ii) a discount rate of 13.7% to 14.2%, and (iii) a payout percentage of 10% based on the earnout provision. The significant unobservable inputs used in Chronix’s contingent consideration valuation on March 31, 2025, included: (i) a discount period, based on the related patent expiration dates, ranging from 9.6 years to 10.5 years, (ii) a discount rate of 13.2% to 13.5%, and (iii) a payout percentage of 10% based on the earnout provision.